ALPS ETF TR - MED BREAKTHGH (SBIO)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,467,528
Share change
-37,746
Total reported value
$71,788,731
Put/Call ratio
33%
Price per share
$48.91
Number of holders
63
Value change
-$1,972,757
Number of buys
28
Number of sells
27

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2021

As of 30 Jun 2021, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,467,528 shares. The largest 10 holders included MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, WELLS FARGO & COMPANY/MN, NTV Asset Management LLC, Cardan Capital Partners, LLC, Tower Research Capital LLC (TRC), LPL Financial LLC, CITADEL ADVISORS LLC, and COMMONWEALTH EQUITY SERVICES, LLC. This page lists 63 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.